Pharmaceutical Technology - October 2022

Pharmaceutical Technology - October 2022

Issue link: https://www.e-digitaleditions.com/i/1481708

Contents of this Issue

Navigation

Page 23 of 66

Ashland's Klucel ™ xtend hydroxypropylcellulose (HPC) can match the release profile of hypromellose controlled-release formulations at half the polymer concentration. This step change matrix former gives you the opportunity to develop smaller tablets and lower operating cost. For more information, visit ashland.com/klucelxtend ® Registered trademark, Ashland or its subsidiaries, registered in various countries ™ Trademark, Ashland or its subsidiaries, registered in various countries ©2022, Ashland PHA22-025 who gets more with less? — klucel ™ xtend hpc

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - October 2022 - Pharmaceutical Technology - October 2022